MannKind presents positive Afrezza clinical data from STAT, AFFINITY studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
uniQure presents clinical data from phase III HOPE-B gene therapy trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Flexion presents preliminary FX201 clinical data at ASGCT meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ocuphire Pharma to present data from pre-clinical studies of APX3330
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Frequency Therapeutics releases new data from two FX-322 clinical studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Leap Therapeutics presents clinical data from Phase 2 trial of DKN-01
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Essa Pharma presents Phase 1 clinical data of EP1-7386
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amicus reports "positive" initial clinical data for CLN3 program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UniQure"s stock rallies 7% on positive safety data for Huntington"s disease treatment
Shares of UniQure gained 7.2% in trading on Monday after the company said an independent data safety monitoring board said there were no safety concerns in a Phase 2/3 clinical trial for its experimental Huntington's disease treatment. The boar.....»»
Sanofi presents amended protocols in fitusiran clinical studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study
Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»
Tracon Pharmaceuticals presents clinical data for Envafolimab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rocket Pharmaceuticals presents new clinical data on FA, LAD-I at ASGCT
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Syndax risk/reward solid following positive clinical data, says Baird
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead reports early positive data in remdesivir studies as COVID-19 drug, though Chinese trial sees no benefit
Gilead Sciences Inc.’s experimental dr.....»»
Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»
Dr. Raymond on more curbside service: With care, "we’ll probably be OK"
The rate of positive Covid-19 tests in Wisconsin increased on Tuesday, breaking a potential multi-day streak, according to Wisconsin Department of Health Services data. More and more are paying attention to that stat because it is one number that will.....»»
Gilead stock tumbles after Stat report on weak data in remdesivir trial in China
Shares of Gilead Sciences Inc. were down 5.3% in trading on Thursday after a Stat News report said a draft of the clinical trial results for remdesivir, an experimental drug being tested as a treatment for COVID-19, showed that the drug did not spe.....»»
COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of Alabama
Two coronavirus vaccine candidates are in the clinics and 42 more are in preclinical studies, according to updated data provided by the World Health Organization on March 20. read more.....»»
NGM Biopharma Shares Spike Higher On Positive NASH Study Results
NGM Biopharmaceuticals Inc (NASDAQ: NGM) is advancing strongly on above-average volume Monday following a positive clinical data readout. read more.....»»
MannKind to present results from multiple studies of Afrezza, BluHale system
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»